. 2020 Feb 27;8:e8637. doi: 10.7717/peerj.8637

Table 1. Patient and tumor characteristics.

	Overall
No. pts	135
No. male (%)	90 (66.7%)
Median age (IQR)	55 (47–62)
No. left kidney (%)	62 (45.9%)
No. anterior face (%)	77 (57.0%)
Median cm tumor largest diameter (IQR)	2.5 (1.7–3.0)
Median ml tumor volume (IQR)	31.3 (6.1–28.6)
Median cm LDTE (IQR)	1.4 (0.0–2.1)
Median R.E.N.A.L. score (IQR)	7.0 (6–8)
Median PADUA score (IQR)	8.2 (7–9)
Median centrality index score (IQR)	3.1 (2.0–3.7)
Median 3D score (IQR)	8.3 (7–10)
Median mins WIT (IQR)	28 (27–30)
No. occurrence of vascular variation (%)	30 (22.2%)
No. tumor volume (%)	–
<10 ml	55 (40.7%)
10–30 ml	50 (37.1%)
>30 ml	30 (22.2%)
No. 2D endophytic/exophytic area rate
<50% endophytic	47 (34.8%)
50%–100% endophytic	67 (49.6%)
Entirely endophytic	21 (15.6%)
No. 3D endophytic/exophytic volume rate
<50% endophytic	42 (31.1%)
50%–100% endophytic	79 (58.5%)
Entirely endophytic	14 (10.4%)
No. LDTE (%)
>2 cm	41 (30.4%)
1–2 cm	50 (37.0%)
<1 cm	44 (32.6%)
No. UCS or renal sinus involvement (%)
None-involved	92 (68.2%)
Only one parameter involved	25 (18.5%)
Both involved	18 (13.3%)
No. 3D score
5–7	57 (42.2%)
8–10	53 (39.3%)
11–14	25 (18.5%)

Notes.

Abbreviations